webinar register page

Webinar banner
Making the Case for PET-CT Myocardial Perfusion Imaging: The Gold Standard for Pharmacologic Stress Testing
Clinicians who treat patients with coronary artery disease (CAD) are faced with the challenge of making a therapeutic decision to recommend revascularization or medical treatment. A conflict often exists making that decision as various methods and metrics assessing myocardial ischemia are discordant with each other. The purpose of this lecture is to provide insight into the measurement of myocardial blood flow (MBF) and its interpretation. The presentation will provide clarity concerning various metrics of MBF, the relationship between the metrics and how these metrics may be discordant with each other and with angiographic findings. The concept of coronary flow capacity (CFC) will be presented and its relevance and impact on clinical practice and patient care will be discussed. Clinicians who participate in this program will gain an appreciation for the use of positron emission tomography (PET) scanning with CFC to help identify patients who will benefit from revascularization.

Dec 8, 2022 07:00 PM in Eastern Time (US and Canada)

* Required information


Colin M. Movsowitz, MD
Cardiac Electrophysiologist @Cardiology Consultants of Philadelphia
Robert M. Bober, MD
Senior Lecturer in Medicine and Cardiology; Director of Molecular Imaging @The Ochsner Clinical School; John Ochsner Heart and Vascular Institute
Herman D. Movsowitz
Cardiologist @Cardiology Consultants of Philadelphia